Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Septerna, Inc. - Common Stock (NQ:SEPN)

47.50 -0.38 (-0.79%)
Delayed Quote Updated: 3:26 PM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Septerna, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors? ↗
Septerna, a clinical-stage biotech focused on GPCR-targeted therapies, reported significant insider selling in its latest SEC filing. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares? ↗
This clinical-stage biotech focused on GPCR-targeted therapies reported a notable insider sale amid rapid share price appreciation. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead ↗
Novo Nordisk’s $4.7B Akero deal boosts its metabolic health pipeline, targeting Eli Lilly’s lead in obesity and liver disease treatments 
Via MarketBeat
Topics World Trade
News headline image
Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside ↗
Septerna gains Buy rating as HC Wainwright highlights undervaluation, strong pipeline, and key partnership with Novo Nordisk in metabolic diseases. 
Via Benzinga
News headline image
This Ventas Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
 
Via Benzinga
News headline image
This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Septerna In The Eyes Of 4 Experts ↗
 
Via Benzinga
News headline image
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly ↗
Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position? 
Via Investor's Business Daily
News headline image
Analysts Think These Stocks Could More Than Double in Value
Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well. 
Via MarketBeat
Topics World Trade
News headline image
Where Septerna Stands With Analysts ↗
 
Via Benzinga
News headline image
3 Stocks That Will Profit From Trump's Drug Price Cut ↗
Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big pharma may be hit hardest. 
Via Benzinga
Topics Government
News headline image
Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role ↗
Novo Nordisk CEO steps down after pressure from shareholders. Former CEO to join board as observer. Company remains optimistic amid mixed signals. 
Via Benzinga
News headline image
Which stocks have an unusual volume on Thursday? ↗
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
Is It Time to Buy the Dip in Novo Nordisk Stock?
Novo Nordisk stock is down nearly 50% in 2025 as competition in the GLP-1 space continues to mount, but the fundamental case for the NVO stock is growing 
Via MarketBeat
Topics Government
News headline image
Top movers analysis in the middle of the day on 2025-05-14: top gainers and losers in today's session. ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Dow Edges Higher; US Crude Oil Inventories Increase ↗
 
Via Benzinga
Topics Stocks
News headline image
Wednesday's pre-market session: top gainers and losers ↗
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs ↗
Novo Nordisk and Septerna enter $2.2 billion deal to develop oral small-molecule therapies targeting obesity, diabetes, and cardiometabolic diseases. 
Via Benzinga
News headline image
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing ↗
The deal is worth up to $2.2 billion, including more than $200 million in upfront and near-term payments. 
Via Investor's Business Daily
News headline image
Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled ↗
Septerna CEO Jeffrey Finer said that the collaboration allows the company to create multiple oral medicines and provides the operational flexibility and resources to advance its portfolio of other... 
Via Stocktwits
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings ↗
 
Via Benzinga
News headline image
Which stocks are moving on Tuesday? ↗
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
Tuesday's session: gap up and gap down stocks ↗
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
News headline image
US Stocks Mixed; NY State Business Activity Rises In February ↗
 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.